Novartis

News

Female doctor with the stethoscope holding heart

Novartis-backed project mobilises patient power against hear...

Novartis has joined forces with a group representing cardiovascular disease patients organisations to push for changes in how health systems handle the world's number one killer.

News

Consternation as NICE rejects Janssen MS drug Ponvory

NICE has delivered its first verdict on NHS funding of Janssen's oral multiple sclerosis drug Ponvory, and it's not good news for patients with the disease waiting for new treatment options

News

Joy as sickle cell patients get access to Novartis' Adakveo ...

People living with sickle cell disease (SCD) in England and Wales will be able to get access to treatment with Novartis' Adakveo, thanks to a special arrangement between the drugmaker and N

R&D

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.<

News

Kite claims a first for CAR-T Tecartus in adult leukaemia

The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an

News

Novartis tightens up its COVID-19 vaccine policy for staff

Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites.

Novartis-backed project mobilises patient power against hear...

Consternation as NICE rejects Janssen MS drug Ponvory

Joy as sickle cell patients get access to Novartis' Adakveo ...

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Kite claims a first for CAR-T Tecartus in adult leukaemia

Novartis tightens up its COVID-19 vaccine policy for staff

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Novartis

Editor's Picks